Zoltán Szekanecz (Z Szekanecz, Zoltan Szekanecz)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 44

Top Venues

Annals of the rheumatic diseases

Nature reviews. Rheumatology

RMD open

Biomedicines

University of Debrecen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Debrecen

Hungary

Head of department :: Rheumatology

Publications

Diána Simon, Dorottya Kacsándi, Anita Pusztai, Boglárka Soós, Edit Végh, György Kerekes, Monika Bodoki, Szilvia Szamosi, Gabriella Szűcs, Zoltán Prohászka, Péter Németh, Tímea Berki, Zoltán Szekanecz
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology. International journal of molecular sciences 25 (6) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Diána Simon, Dorottya Kacsándi, Anita Pusztai, Boglárka Soós, Edit Végh, György Kerekes, Monika Bodoki, Szilvia Szamosi, Gabriella Szűcs, Zoltán Prohászka, Péter Németh, Tímea Berki, Zoltán Szekanecz
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology. International journal of molecular sciences 25 (6) (2024)
Christina Charles-Schoeman, Roy M Fleischmann, Eduardo Mysler, Maria Greenwald, Steven R Ytterberg, Gary G Koch, Deepak L Bhatt, Cunshan Wang, Ted R Mikuls, All-Shine Chen, Carol A Connell, John C Woolcott, Sujatha Menon, Yan Chen, Kristen Lee, Zoltán Szekanecz
Risk of Venous Thromboembolism with Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-enriched Rheumatoid Arthritis Patients. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Publisher Correction: Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology (2024)
Christina Charles-Schoeman, Roy M Fleischmann, Eduardo Mysler, Maria Greenwald, Steven R Ytterberg, Gary G Koch, Deepak L Bhatt, Cunshan Wang, Ted R Mikuls, All-Shine Chen, Carol A Connell, John C Woolcott, Sujatha Menon, Yan Chen, Kristen Lee, Zoltán Szekanecz
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients. Arthritis & rheumatology (Hoboken, N.J.) 76 (8) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Christina Charles-Schoeman, Roy M Fleischmann, Eduardo Mysler, Maria Greenwald, Steven R Ytterberg, Gary G Koch, Deepak L Bhatt, Cunshan Wang, Ted R Mikuls, All-Shine Chen, Carol A Connell, John C Woolcott, Sujatha Menon, Yan Chen, Kristen Lee, Zoltán Szekanecz
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Diána Simon, Dorottya Kacsándi, Anita Pusztai, Boglárka Soós, Edit Végh, György Kerekes, Monika Bodoki, Szilvia Szamosi, Gabriella Szűcs, Zoltán Prohászka, Péter Németh, Tímea Berki, Zoltán Szekanecz
Natural Autoantibodies in Biologic-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients: Associations with Vascular Pathophysiology. International journal of molecular sciences 25 (6) (2024)
Ida K Haugen, David T Felson, Abhishek Abhishek, Francis Berenbaum, Sita Bierma-Zeinstra, Krysia S Dziedzic, John James Edwards, Martin Englund, Merete Hermann-Eriksen, Gabriel Herrero-Beaumont, Catherine Hill, Mariko L Ishimori, Helgi Jonsson, Teemu Karjalainen, Ying Ying Leung, Emmanuel Maheu, Christian D Mallen, Michelle M Marshall, Rikke H Moe, Roberta Ramonda, Valentin Ritschl, Marco Jpf Ritt, Tanja Alexandra Stamm, Zoltán Szekanecz, Florus van der Giesen, Lotte A van de Stadt, Coen van der Meulen, Ruth Wittoek, Elsie Greibrokk, Hellen Laheij, Margreet Kloppenburg
2023 EULAR classification criteria for hand osteoarthritis. Annals of the rheumatic diseases (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Zoltán Szekanecz, Maya H Buch, Christina Charles-Schoeman, James B Galloway, George Athanasios Karpouzas, Lars Erik Kristensen, Steven R Ytterberg, Attila Hamar, Roy M Fleischmann
Efficacy and safety of JAK inhibitors in rheumatoid arthritis: update for the practising clinician. Nature reviews. Rheumatology 20 (2) (2024)
Éva Rákóczi, Gusztáv Magócs, Sára Kovács, Béla Nagy, Gabriella Szűcs, Zoltán Szekanecz
Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine. Diagnostics (Basel, Switzerland) 13 (3) (2023)
György Kerekes, Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Mónika Katkó, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Zsolt Hascsi, Mariann Harangi, Katalin Hodosi, György Panyi, Tamás Seres, Gabriella Szűcs, Zoltán Szekanecz
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis. Rheumatology (Oxford, England) 62 (SI3) (2023)
Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A Gergely, Eszter Csánky, Zoltán Szekanecz
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study. Biomedicines 11 (2) (2023)
Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A Gergely, Eszter Csánky, Zoltán Szekanecz
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study. Biomedicines 11 (2) (2023)
Zsófia Kardos, Miklós Szabó, Zsuzsanna Baráth, Ágnes Miksi, Csaba Oláh, Ádám Kozma, József A Gergely, Eszter Csánky, Zoltán Szekanecz
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study. Biomedicines 11 (2) (2023)
Éva Rákóczi, Gusztáv Magócs, Sára Kovács, Béla Nagy, Gabriella Szűcs, Zoltán Szekanecz
Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Maxime Dougados, Christina Charles-Schoeman, Zoltán Szekanecz, Jon T Giles, Steven R Ytterberg, Deepak L Bhatt, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Carol A Connell, Arne Yndestad, Jose L Rivas, Maya H Buch
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme. Annals of the rheumatic diseases (2023)
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Nóra Obajed Al-Ali, Sára Rebeka Tóth, László Váróczy, László Imre Pinczés, Pál Soltész, Zoltán Szekanecz, György Kerekes
One Step Back from Bedside to the Bench-How Do Different Arterial Stiffness Parameters Behave in Relation to Peripheral Resistance? Diagnostics (Basel, Switzerland) 13 (18) (2023)
Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles, Steven R Ytterberg, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Jose L Rivas, Arne Yndestad, Carol A Connell, Zoltán Szekanecz
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance. Annals of the rheumatic diseases (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Attila Hamar, Zsolt Hascsi, Anita Pusztai, Monika Czókolyová, Edit Végh, Zsófia Pethő, Katalin Gulyás, Boglárka Soós, György Kerekes, Éva Szekanecz, Katalin Hodosi, Sándor Szántó, Gabriella Szűcs, Tamás Seres, Zoltán Szekanecz, Szilvia Szamosi
Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status. RMD open 7 (3) (2022)
Iain B McInnes, AnnaMaria Iagnocco, Daniel Aletaha, Xenofon Baraliakos, Johannes W J Bijlsma, Elsa F Mateus, Zoltán Szekanecz, Thea P M Vliet Vlieland, Josef S Smolen
Reflections on a contemporary European tragedy. Annals of the rheumatic diseases 81 (6) (2022)
Ida K Haugen, David T Felson, Abhishek Abhishek, Francis Berenbaum, John James Edwards, Gabriel Herrero Beaumont, Merete Hermann-Eriksen, Catherine L Hill, Mariko Ishimori, Helgi Jonsson, Teemu Karjalainen, Ying Ying Leung, Emmanuel Maheu, Christian D Mallen, Rikke Helene Moe, Roberta Ramonda, Valentin Ritschl, Tanja Alexandra Stamm, Zoltán Szekanecz, Florus J van der Giesen, Marco J P F Ritt, Ruth Wittoek, Ingvild Kjeken, Nina Østerås, Lotte A van de Stadt, Martin Englund, Krysia S Dziedzic, Michelle M Marshall, Sita Bierma-Zeinstra, Paul Hansen, Elsie Greibrokk, Wilma Smeets, Margreet Kloppenburg
Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2). RMD open 8 (1) (2022)
Pavel V Ovseiko, Laure Gossec, Laura Andreoli, Uta Kiltz, Leonieke van Mens, Neelam Hassan, Marike van der Leeden, Heidi J Siddle, Alessia Alunno, Iain B McInnes, Nemanja S Damjanov, Florence Apparailly, Caroline Ospelt, Irene E van der Horst-Bruinsma, Elena Nikiphorou, Katie L Druce, Zoltán Szekanecz, Alexandre Sepriano, Tadej Avcin, George Bertsias, Georg Schett, Anne-Maree Keenan, Linda H Pololi, Laura C Coates
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD open 8 (2) (2022)
Monika Czókolyová, Attila Hamar, Anita Pusztai, Gábor Tajti, Edit Végh, Zsófia Pethő, Nóra Bodnár, Ágnes Horváth, Boglárka Soós, Szilvia Szamosi, Anita Szentpéteri, Ildikó Seres, Mariann Harangi, György Paragh, György Kerekes, Levente Bodoki, Andrea Domján, Katalin Hodosi, Tamas Seres, Gyorgy Panyi, Zoltán Szekanecz, Gabriella Szűcs
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis. Biomolecules 12 (10) (2022)
George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Angel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan B Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savinio Sciascia, Elisabet Svenungsson, Zoltán Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary John Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G G Tektonidou
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Annals of the rheumatic diseases 81 (6) (2022)
Boglárka Soós, Ágnes Szentpétery, Hennie G Raterman, Willem F Lems, Harjit Pal Bhattoa, Zoltán Szekanecz
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nature reviews. Rheumatology 18 (5) (2022)
György Nagy, Pál Géher, László Tamási, Edit Drescher, Péter Keszthelyi, Judit Pulai, László Czirják, Zoltán Szekanecz, Gergely Kiss, László Kovács
Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study. Rheumatology advances in practice 6 (2) (2022)
Jeffrey I Weitz, Zoltán Szekanecz, Christina Charles-Schoeman, Ivana Vranic, Burak Sahin, Sara A Paciga, Zhenyu Wang, Craig Hyde, David A Martin
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD open 8 (2) (2022)
Zoltán Szekanecz, Attila Balog, Tamás Constantin, László Czirják, Pál Géher, László Kovács, Gábor Kumánovics, György Nagy, Éva Rákóczi, Szilvia Szamosi, Gabriella Szűcs, István Vályi-Nagy
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients. Expert reviews in molecular medicine 24 (2022)
György Nagy, Nadia M T Roodenrijs, Paco M J Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Polina Pchelnikova, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest H S Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Johannes W J Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Sophie Dumas, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimmie L Hyrich, Ulf Mueller-Ladner, Raluca Bianca Dumitru, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases (2021)
Zoltán Szekanecz, Iain B McInnes, Larissa Valor-Méndez, Szilvia Szamosi, Szilvia Benkő, Gabriella Szűcs
Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nature reviews. Rheumatology 17 (10) (2021)
A Hamar, Zoltán Szekanecz, A Pusztai, M Czókolyová, E Végh, Z Pethő, N Bodnár, K Gulyás, Á Horváth, B Soós, L Bodoki, H P Bhattoa, G Nagy, G Tajti, G Panyi, É Szekanecz, A Domján, K Hodosi, S Szántó, G Szűcs, S Szamosi
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (8) (2021)
Anita Pusztai, Attila Hamar, Ágnes Horváth, Katalin Gulyás, Edit Végh, Nóra Bodnár, György Kerekes, Monika Czókolyová, Szilvia Szamosi, Levente Bodoki, Katalin Hodosi, Andrea Domján, Gábor Nagy, Ibolya Szöllősi, Luis R Lopez, Eiji Matsuura, Zoltán Prohászka, Sándor Szántó, Zoltán Nagy, Yehuda Shoenfeld, Zoltán Szekanecz, Gabriella Szűcs
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy. The Journal of rheumatology 48 (6) (2020)
György Nagy, Nadia M T Roodenrijs, Paco Mj Welsing, Melinda Kedves, Attila Hamar, Marlies C van der Goes, Alison Kent, Margot Bakkers, Etienne Blaas, Ladislav Senolt, Zoltán Szekanecz, Ernest Choy, Maxime Dougados, Johannes W G Jacobs, Rinie Geenen, Hans Wj Bijlsma, Angela Zink, Daniel Aletaha, Leonard Schoneveld, Piet van Riel, Loriane Gutermann, Yeliz Prior, Elena Nikiphorou, Gianfranco Ferraccioli, Larissa Valor-Méndez, Kimme L Hyrich, Ulf Mueller-Ladner, Maya H Buch, Iain B McInnes, Désirée Mfm van der Heijde, Jacob M van Laar
EULAR definition of difficult-to-treat rheumatoid arthritis. Annals of the rheumatic diseases 80 (1) (2020)
Csaba Oláh, Zsófia Kardos, László Kostyál, Katalin Hodosi, László Tamási, Dániel Bereczki, Zoltán Szekanecz
Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study. Rheumatology international 40 (6) (2020)
Zoltán Szekanecz
Reply to: Comment on "effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis" by Cure et al. Rheumatology international 40 (3) (2020)
László Gulácsi, Zsombor Zrubka, Valentin Brodszky, Fanni Rencz, Rieke E Alten, Zoltán Szekanecz, Márta Péntek
Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis. Advances in therapy 36 (3) (2019)
Zsombor Zrubka, László Gulácsi, Valentin Brodszky, Fanni Rencz, Rieke E Alten, Zoltán Szekanecz, Márta Péntek
Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis. Expert review of pharmacoeconomics & outcomes research 19 (5) (2019)
László Andrássy, Izabella Gomez, Ágnes Horváth, Katalin Gulyás, Zsófia Pethö, Balázs Juhász, Harjit Pal Bhattoa, Zoltán Szekanecz
Laser-induced plasma spectroscopy (LIPS): use of a geological tool in assessing bone mineral content. Lasers in medical science 33 (6) (2018)
Anna Pallai, Beáta Kiss, György Vereb, Marietta Armaka, George Kollias, Zoltán Szekanecz, Zsuzsa Szondy
Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications. Journal of immunology (Baltimore, Md. : 1950) 196 (3) (2016)

Zoltán Szekanecz.css-eqlu8i{font-size:small;padding-left:4px;} (Z Szekanecz, Zoltan Szekanecz)

Publication Activity (10 Years)

Top Topics

Top Venues

Zoltán Szekanecz (Z Szekanecz, Zoltan Szekanecz)